← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

▼ SELL 10b5-1 Plan

$ Value

$60K

Shares

10,834

Price

$6

Filed

Apr 1

Insider

Name

Brady James Aloysius

Title

CIK

0001916987

Roles

Director

Transaction Details

Transaction Date

2026-03-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

89,166

Footnotes

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.290 to $5.630, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001916987-26-000002

Form Type

4

Issuer CIK

0001867096

Brady James Aloysius's History

Date Ticker Type Value
2026-03-30 XERS $60K
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-08-01 VRNA M $0
2025-08-01 VRNA $11K

Other Insiders at XERS (90d)

Insider Bought Sold Last
Hecht Beth
See Remarks
$100K 2026-04-01